Researchers conducted a meta-analysis of 181 publications that contrasted the neural activity of subjects with anxiety with subjects in control groups or healthy subjects in a safe condition with healthy subjects in an unpredictable-threat condition.
59% of Americans report that COVID-19 is affecting their daily lives, and 36% of respondents to the poll say that COVID-19 is taking a toll on their mental health.
Heart rate variability factors may predict therapeutic response in patients with major depressive disorder and panic disorder.
Palo Alto Health Sciences announced that the FDA has granted clearance to Freespira, a new digital therapeutic for the treatment of PTSD.
Patients who respond to panic-focused psychotherapy appear to maintain their improvements following treatment termination.
Therapeutic response to antidepressants is highly variable, which may be partially due to associated side effects.
Preemies may possess elevated levels of characteristics that put them at risk for peer victimization, including more anxiety and depression.
New tools and therapies are available for the approximately 6 million US adults with panic disorder.
Patients with sleep apnea appear to be predisposed to panic disorder, based on a study conducted in Taiwan.
A new spectrum disorder, known by the acronym ALPIM, associates panic disorder with several physical illnesses.
